A detailed history of Pko Investment Management Joint Stock CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 16,000 shares of BMY stock, worth $977,120. This represents 0.11% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$977,120
% of portfolio
0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 13, 2025

BUY
$51.92 - $59.94 $830,720 - $959,040
16,000 New
16,000 $905 Million
Q3 2024

Mar 13, 2025

SELL
$39.66 - $51.75 $555,240 - $724,500
-14,000 Reduced 41.18%
20,000 $1.03 Billion
Q1 2024

Mar 13, 2025

SELL
$47.98 - $54.4 $451,059 - $511,414
-9,401 Reduced 31.98%
20,000 $1.09 Billion
Q4 2023

Mar 13, 2025

BUY
$48.48 - $57.85 $763,850 - $911,484
15,756 Added 86.36%
34,000 $1.74 Billion
Q2 2023

Mar 13, 2025

BUY
$63.71 - $70.74 $700,810 - $778,140
11,000 Added 47.83%
34,000 $2.17 Billion
Q1 2023

Mar 13, 2025

SELL
$65.71 - $74.53 $65,710 - $74,530
-1,000 Reduced 4.17%
23,000 $1.59 Billion
Q4 2022

Mar 13, 2025

BUY
$68.48 - $81.09 $68,480 - $81,090
1,000 Added 4.55%
23,000 $1.65 Billion
Q3 2022

Mar 13, 2025

BUY
$0.13 - $76.84 $780 - $461,040
6,000 Added 37.5%
22,000 $1.56 Billion
Q2 2022

Mar 13, 2025

SELL
$72.62 - $79.98 $72,620 - $79,980
-1,000 Reduced 4.0%
24,000 $1.85 Billion
Q1 2022

Mar 13, 2025

SELL
$61.48 - $73.72 $1.84 Million - $2.21 Million
-30,000 Reduced 54.55%
25,000 $1.83 Billion
Q4 2021

Mar 13, 2025

BUY
$53.63 - $62.52 $1.37 Million - $1.6 Million
25,599 Added 87.07%
55,000 $3.43 Billion
Q4 2020

Mar 13, 2025

BUY
$57.74 - $65.43 $773,773 - $876,827
13,401 Added 83.76%
29,401 $1.82 Billion
Q4 2019

Mar 13, 2025

BUY
$49.21 - $64.19 $549,035 - $716,167
11,157 Added 61.15%
29,401 $1.89 Billion
Q3 2019

Mar 13, 2025

BUY
$42.77 - $50.71 $95,975 - $113,793
2,244 Added 14.03%
18,244 $925 Million
Q3 2018

Mar 13, 2025

BUY
$55.19 - $62.25 $123,846 - $139,689
2,244 Added 14.03%
18,244 $1.13 Billion
Q2 2018

Mar 13, 2025

SELL
$50.53 - $62.98 $287,869 - $358,797
-5,697 Reduced 23.8%
18,244 $1.01 Billion
Q4 2017

Mar 13, 2025

BUY
$59.94 - $65.35 $176,463 - $192,390
2,944 Added 14.02%
23,941 $1.47 Billion
Q3 2017

Mar 13, 2025

BUY
$55.23 - $63.74 $434,494 - $501,442
7,867 Added 59.92%
20,997 $1.34 Billion
Q2 2017

Mar 13, 2025

BUY
N/A
7,651 Added 139.64%
13,130 $732 Million
Q1 2017

Mar 13, 2025

SELL
N/A
-10,521
5,479 $298 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $130B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pko Investment Management Joint Stock CO Portfolio

Follow Pko Investment Management Joint Stock CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.